Table 1.

The anticancer activities of compounds 6-20.

Compd.	IC50 (μM)		Compd.	IC50 (μM)
	Bel-7402	HT-1080		Bel-7402	HT-1080
6	>300	>300	14	54.1	30.8
7	72.5	52.1	15	44.6	36.3
8	67.3	57.4	16	42.1	32.2
9	>300	237	17	13.9	28.4
10	>300	280	18	22.1	29.3
11	45.8	35.1	19	12.3	6.1
12	77.6	41.4	20	22.2	14.8
13	>300	261.9	cisplatin	35.5	22.7